BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33171177)

  • 21. Bakuchiol exhibits anti-metastasis activity through NF-κB cross-talk signaling with AR and ERβ in androgen-independent prostate cancer cells PC-3.
    Miao L; Yun X; Tao R; Wang Y; Fan G; Zhu Y; Cai T; Zhu Z; Yan C; Gao X
    J Pharmacol Sci; 2018 Sep; 138(1):1-8. PubMed ID: 30236540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.
    Shigemura K; Sung SY; Kubo H; Arnold RS; Fujisawa M; Gotoh A; Zhau HE; Chung LW
    Prostate; 2007 May; 67(7):722-31. PubMed ID: 17342749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivo.
    Thomas C; Zoubeidi A; Kuruma H; Fazli L; Lamoureux F; Beraldi E; Monia BP; MacLeod AR; Thüroff JW; Gleave ME
    Mol Cancer Ther; 2011 Feb; 10(2):347-59. PubMed ID: 21216933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.
    Meng D; Yang S; Wan X; Zhang Y; Huang W; Zhao P; Li T; Wang L; Huang Y; Li T; Li Y
    Int J Biochem Cell Biol; 2016 Apr; 73():30-40. PubMed ID: 26827675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AZGP1 is androgen responsive and involved in AR-induced prostate cancer cell proliferation and metastasis.
    Cao R; Ke M; Wu Q; Tian Q; Liu L; Dai Z; Lu S; Liu P
    J Cell Physiol; 2019 Aug; 234(10):17444-17458. PubMed ID: 30820960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The activation of OR51E1 causes growth suppression of human prostate cancer cells.
    Maßberg D; Jovancevic N; Offermann A; Simon A; Baniahmad A; Perner S; Pungsrinont T; Luko K; Philippou S; Ubrig B; Heiland M; Weber L; Altmüller J; Becker C; Gisselmann G; Gelis L; Hatt H
    Oncotarget; 2016 Jul; 7(30):48231-48249. PubMed ID: 27374083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PLCε knockdown enhances the radiosensitivity of castration‑resistant prostate cancer via the AR/PARP1/DNA‑PKcs axis.
    Pu J; Li T; Liu N; Luo C; Quan Z; Li L; Wu X
    Oncol Rep; 2020 May; 43(5):1397-1412. PubMed ID: 32323799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer.
    Kashiwagi E; Shiota M; Yokomizo A; Inokuchi J; Uchiumi T; Naito S
    Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):10-7. PubMed ID: 24518515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line.
    Liu C; Chen Z; Hu X; Wang L; Li C; Xue J; Zhang P; Chen W; Jiang A
    Mol Med Rep; 2015 Jun; 11(6):4625-32. PubMed ID: 25673182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LGR4 protects hepatocytes from injury in mouse.
    Li Z; Liu S; Lou J; Mulholland M; Zhang W
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G123-G131. PubMed ID: 30406697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen ablation elicits PP1-dependence for AR stabilization and transactivation in prostate cancer.
    Liu X; Han W; Gulla S; Simon NI; Gao Y; Liu J; Wang L; Yang H; Zhang X; Chen S
    Prostate; 2016 May; 76(7):649-61. PubMed ID: 26847655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LGR4 silence aggravates ischemic injury by modulating mitochondrial function and oxidative stress via ERK signaling pathway in H9c2 cells.
    Chen T; Qiao X; Cheng L; Liu M; Deng Y; Zhuo X
    J Mol Histol; 2021 Apr; 52(2):363-371. PubMed ID: 33559814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
    Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
    Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.
    Bennett NC; Hooper JD; Johnson DW; Gobe GC
    Prostate; 2014 May; 74(5):478-87. PubMed ID: 24375805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PYK2 via S6K1 regulates the function of androgen receptors and the growth of prostate cancer cells.
    Hsiao YH; Huang YT; Hung CY; Kuo TC; Luo FJ; Yuan TC
    Endocr Relat Cancer; 2016 Aug; 23(8):651-63. PubMed ID: 27492635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression.
    Shiota M; Takeuchi A; Song Y; Yokomizo A; Kashiwagi E; Uchiumi T; Kuroiwa K; Tatsugami K; Fujimoto N; Oda Y; Naito S
    Endocr Relat Cancer; 2011 Aug; 18(4):505-17. PubMed ID: 21652770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients.
    Wang T; Abou-Ouf H; Hegazy SA; Alshalalfa M; Stoletov K; Lewis J; Donnelly B; Bismar TA
    J Mol Med (Berl); 2016 Dec; 94(12):1411-1422. PubMed ID: 27534968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menin Enhances Androgen Receptor-Independent Proliferation and Migration of Prostate Cancer Cells.
    Kim T; Jeong K; Kim E; Yoon K; Choi J; Park JH; Kim JH; Kim HS; Youn HD; Cho EJ
    Mol Cells; 2022 Apr; 45(4):202-215. PubMed ID: 35014621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.
    Cioni B; Nevedomskaya E; Melis MHM; van Burgsteden J; Stelloo S; Hodel E; Spinozzi D; de Jong J; van der Poel H; de Boer JP; Wessels LFA; Zwart W; Bergman AM
    Mol Oncol; 2018 Aug; 12(8):1308-1323. PubMed ID: 29808619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.